Radiometer cuts profit forecast:
This article was originally published in Clinica
Radiometer, the Danish manufacturer of blood gas analysers, has cut its profit expectations for the 12 months to the end of April. It cut profit forecasts 10% to DKr 180 million ($27 million) on sales of DKr 1,770 million, unchanged from a forecast made last June. Radiometer has decided to abandon acquisition plans and concentrate on developing its medical division. It is looking for a partner that will help it expand its market position, Reuters reports.
You may also be interested in...
The companies think they can build out the indications for zuranalone and SAGE-324 faster and more broadly and commercialize the drugs more effectively as partners.
The guidance document allows manufacturers to promote their dry-heat systems for mask bioburden reduction if they meet certain standards.
The US Medicare agency is letting ambulatory surgical centers and patient homes be reimbursed as in-patient hospitals for patient care purposes during the pandemic.